An Open-Label, Fixed-Sequence Study to Assess the Effects of Multiple-Dose Probenecid on the Multiple-Dose Pharmacokinetics of Canagliflozin in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 16 Feb 2012
At a glance
- Drugs Canagliflozin; Probenecid
- Indications Gout; Obesity; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 23 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Oct 2011 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 05 Sep 2011 New trial record